GILD•benzinga•
Goldman Sachs Maintains Neutral on Gilead Sciences, Raises Price Target to $96
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga